FindTrial
Sign In

To evaluate the clinical performance of CEREBO in detecting intracranial injury in patients with traumatic brain injury

Role of Non invasive Modalities in detecting intracranial haemorrhage and its radiological correlation - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071639
Enrollment
63
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S068- Other specified intracranial injuries

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Bioscan Research Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with suspected TBI referred for head CT/MRI scan

Exclusion criteria

Exclusion criteria: Patients with scalp bruises and hematoma

Design outcomes

Primary

MeasureTime frame
Sensitivity, Specificity, Accuracy and other parameters of CEREBO in determining presence or absence of an intracranial bleedTimepoint: 3 years—

Secondary

MeasureTime frame
1. To assess the number of referrals that CEREBO could have prevented from other sites to the study site 2. To assess the usability of CEREBO® among healthcare professionals through survey questionnairesTimepoint: 3 years—

Countries

India

Contacts

Public ContactDr Viral Vasani

Wockhardt Hospitals, Rajkot

vmvasani@gmail.com9742353191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026